About Selah Genomics
Selah Genomics is a company based in Greenville (United States) founded in 2012 was acquired by EKF in April 2014. Selah Genomics has raised $900 thousand across 2 funding rounds from investors including EKF and VentureSouth. Selah Genomics operates in a competitive market with competitors including Omniome, Novogene Corporation, Rejuvenate Bio, HitGen and Source BioScience, among others.
- Headquarter Greenville, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Selah Genomics Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Selah Genomics
Selah Genomics has successfully raised a total of $900K across 2 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $450 thousand completed in March 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Selah Genomics
Selah Genomics has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include EKF and VentureSouth.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage ventures in the Southeast are supported by VentureSouth.
|
Locked | Locked | Locked | |
|
Point-of-care and laboratory blood analyzers are developed by EKF.
|
Locked | Locked | Locked |
Investor details for Selah Genomics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Selah Genomics
Investment portfolio details for Selah Genomics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Selah Genomics
Detailed financials for Selah Genomics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Selah Genomics Comparisons
Peer comparison for Selah Genomics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Selah Genomics
Selah Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Omniome, Novogene Corporation, Rejuvenate Bio, HitGen and Source BioScience, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genome sequencing platform is provided for clinical diagnostics.
|
|
| Locked | Locked | Locked |
Genomic services and solutions with NGS expertise are provided.
|
|
| Locked | Locked | Locked |
Gene-editing platform and anti-aging therapy for dogs are developed.
|
|
| Locked | Locked | Locked |
DNA-encoded libraries are developed for drug discovery applications.
|
|
| Locked | Locked | Locked |
Multiple genomic services are provided for analysis and diagnostics.
|
|
| Locked | Locked | Locked |
NGS-based diagnostic solutions for neonatal screening are developed.
|
Detailed competitors of Selah Genomics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Selah Genomics
Complete news archive for Selah Genomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Selah Genomics
Selah Genomics was founded in 2012 and raised its 1st funding round 1 year after it was founded.
Selah Genomics is headquartered in Greenville, United States.
Selah Genomics is a funded company, having raised a total of $900K across 2 funding rounds to date.
Selah Genomics was founded in 2012 in Greenville, United States, as a clinical diagnostic company focused on the genomics sector. Services are offered to healthcare providers and the pharmaceutical industry, including next-generation sequencing, companion diagnostics for drug development, RNA sequencing, targeted sequencing from fresh-frozen or FFPE tissue, exome sequencing, qPCR, and bioinformatics support. A biorepository with clinical and molecular annotations of solid tumors is maintained.
Selah Genomics's top competitors include Novogene Corporation, Singular Genomics and Source BioScience.
Selah Genomics has 2 investors. Key investors include EKF, and VentureSouth.